Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

85.7K
Overview
85.7K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

2.2K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.2K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

2.7K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.7K
Tissue Transplantation01:24

Tissue Transplantation

1.2K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.2K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.3K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

603
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
603

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Current Management of Patients with Proximal Femur Fractures Receiving Antiplatelet and Anticoagulant Therapy].

Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca·2024
Same author

Factors influencing overall survival and GvHD development after allogeneic hematopoietic stem cell transplantation - single centre experience.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2024
Same author

Cardiovascular complications among hematopoietic cell transplantation survivors - the role of cardiomarkers.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2022
Same author

Influence of different spectra of NOTCH3 variants on the clinical phenotype of CADASIL - experience from Slovakia.

Neurogenetics·2022
Same author

Metabolic syndrome in long-term survivors after allogeneic hematopoietic stem cell transplantation.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2022
Same author

Cardiovascular events and atherogenic lipid profile in chronic myeloid leukemia patients treated with nilotinib versus imatinib.

Bratislavske lekarske listy·2021

Related Experiment Video

Updated: Mar 16, 2026

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

8.4K

Graft-versus-host disease management.

M Mistrik, E Bojtarova, L Sopko

    Bratislavske Lekarske Listy
    |August 23, 2016
    PubMed
    Summary

    Graft-versus-host disease (GVHD) significantly impacts allogeneic stem cell transplant outcomes, causing mortality and reduced quality of life. Advancements in GVHD management are crucial for improving patient survival and well-being.

    Keywords:
    acute graft-versus-host diseaseallogeneic hematopoietic cell transplantationchronic graft-versus-host diseasefirst line graft-versus-host disease treatmentgraft-versus-host diseasesteroid-refractory graft-versus-host disease.

    More Related Videos

    Induction of Graft-versus-host Disease and In Vivo T Cell Monitoring Using an MHC-matched Murine Model
    10:29

    Induction of Graft-versus-host Disease and In Vivo T Cell Monitoring Using an MHC-matched Murine Model

    Published on: August 29, 2012

    16.3K
    Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR
    06:06

    Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR

    Published on: May 23, 2019

    7.7K

    Related Experiment Videos

    Last Updated: Mar 16, 2026

    Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
    08:05

    Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

    Published on: March 17, 2020

    8.4K
    Induction of Graft-versus-host Disease and In Vivo T Cell Monitoring Using an MHC-matched Murine Model
    10:29

    Induction of Graft-versus-host Disease and In Vivo T Cell Monitoring Using an MHC-matched Murine Model

    Published on: August 29, 2012

    16.3K
    Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR
    06:06

    Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR

    Published on: May 23, 2019

    7.7K

    Area of Science:

    • Hematology
    • Immunology
    • Transplantation Medicine

    Background:

    • Graft-versus-host disease (GVHD) is a primary complication of allogeneic hematopoietic-stem cell transplantation (HSCT).
    • Clinically significant acute GVHD affects 20-65% of patients, contributing to 50% of non-relapse mortality.
    • Chronic GVHD impacts up to 70% of survivors, leading to long-term morbidity and decreased quality of life.

    Purpose of the Study:

    • To review current advancements in the diagnosis and management of GVHD.
    • To identify essential requirements for GVHD diagnosis and treatment amidst evolving therapeutic options.
    • To address the increasing incidence of GVHD due to changing transplantation practices.

    Main Methods:

    • Literature review of recent findings in GVHD research.
    • Analysis of factors contributing to the rising incidence of GVHD.
    • Discussion of diagnostic criteria and treatment strategies.

    Main Results:

    • GVHD remains a significant barrier to successful HSCT outcomes.
    • The incidence of chronic GVHD is increasing due to factors like broader donor selection and use of peripheral blood stem cells.
    • Significant advancements in GVHD management are emerging, necessitating updated guidelines.

    Conclusions:

    • Effective GVHD management is critical for improving HSCT success rates.
    • Standardized diagnostic and treatment protocols are needed to ensure optimal patient care.
    • Further research and clinical guidelines are essential to navigate new GVHD therapeutic landscapes.